CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 454013-454097 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"1 to 35) were analysed for anti-GAD Ab using a commercial GAD-65Ab radioimmunoassay.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T70058","span":{"begin":0,"end":84},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T70058","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T207","span":{"begin":0,"end":84},"obj":"Sentence"}],"attributes":[{"subj":"T207","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3102","span":{"begin":32,"end":35},"obj":"Disease"},{"id":"T3103","span":{"begin":58,"end":61},"obj":"Disease"},{"id":"T93139","span":{"begin":32,"end":35},"obj":"Disease"},{"id":"T32109","span":{"begin":58,"end":61},"obj":"Disease"}],"attributes":[{"id":"A3102","pred":"mondo_id","subj":"T3102","obj":"http://purl.obolibrary.org/obo/MONDO_0001942"},{"id":"A3103","pred":"mondo_id","subj":"T3103","obj":"http://purl.obolibrary.org/obo/MONDO_0001942"},{"id":"A49801","pred":"mondo_id","subj":"T93139","obj":"http://purl.obolibrary.org/obo/MONDO_0001942"},{"id":"A20523","pred":"mondo_id","subj":"T32109","obj":"http://purl.obolibrary.org/obo/MONDO_0001942"},{"subj":"T3102","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T3103","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T93139","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T32109","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#cc93ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93ecb2"},{"id":"CORD-19-PD-MONDO","color":"#ec9893"}]}]}}